期刊文献+

人肺腺癌细胞株A549和A549/DDP的比较蛋白质组学研究 被引量:3

Comparative proteomic analysis of human lung adenocarcinoma A549 and A549/DDP cells
原文传递
导出
摘要 目的:比较人肺癌细胞株A549和顺铂(cisplatin,DDP)耐药细胞株A549/DDP中的蛋白表达差异。方法:DDP诱导A549细胞建立DDP耐药细胞株A549/DDP。应用蛋白质组学技术分离鉴定A549和A549/DDP细胞中差异表达的蛋白质,通过real-timePCR、蛋白质印迹法和免疫细胞化学法对部分差异蛋白进行验证;应用生物学信息检索分析差异蛋白的功能。结果:A549和A549/DDP细胞中有8个蛋白质点的表达差异>5倍,分别为POTE、FH(fumarate hydratase)、PDE(phosphodiesterase)、AKR1C1(aldo-keto reductase family1,memberC1)、DDH2(dihydrodiol dehydrogenase 2)、S100A10、prefoldin subunit2和核内转运蛋白,这些蛋白与细胞代谢、凋亡、增殖、解毒和信号转导等有关。Real-timePCR、蛋白质印迹法和免疫细胞化学法验证结果与蛋白质组学研究结果一致。结论:鉴定得到的A549和A549/DDP细胞中的差异蛋白为研究肺癌细胞DDP耐药提供新依据。 Objective:To compare the differentially expressed proteins between A549 cells and DDP(cisplatin)-resistant A549/DDP cells.Methods:A549 cells were exposed to DDP for developing the DDP-resistant A549/DDP cells.The differentially expressed proteins in the A549 and A549/DDP cells were separated and identified by proteomics approach.A part of the differentially expressed proteins were validated by real-time PCR,Western blotting and immunocytochemistry.The functions of these proteins were analyzed by bioinformatics method.Results:There were 8 differentially expressed proteins including POTE,FH(fumarate hydratase),PDE(phosphodiesterase),AKR1C1(aldo-keto reductase family 1 member C1),DDH2(dihydrodiol dehydrogenase 2),S100A10,prefoldin subunit 2,and karyopherin beta2-Ran GppNHp nuclear transport complex between A549 and A549/DDP cells,and the difference in expression was more than 5-fold.These proteins were related with cellular metabolism,apoptosis,cell proliferation,detoxification and signal transduction.The validation results of real-time PCR,Western blotting and immunocytochemistry were consistent with the results of proteomic analysis.Conclusion:The differentially expressed proteins between A549 and A549/DDP cells provide some new clues for the study of DDP-resistant lung cancer cells.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第3期170-176,共7页 Tumor
基金 国家自然科学基金资助项目(编号:30873023)
关键词 非小细胞肺 蛋白质组学 药物耐受性 顺铂 Carcinoma non-small cell lung Proteomics Drug tolerance Cisplatin.
  • 相关文献

参考文献29

  • 1JEMAL A,SIEGEL R,XU J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
  • 2TRIANO L R,DESHPANDE H,GETTINGER S N.Management of patients with advanced non-small cell lung cancer:current and emerging options[J].Drugs,2010,70(2):167-179.
  • 3ANDREWS J,YEH P,PAO W,et al.Molecular predictors of response to chemotherapy in non-small cell lung cancer[J].Cancer J,2011,17(2):104-113.
  • 4LAGE H.Proteomic approaches for investigation of therapy resistance in cancer[J].Proteomics ClinAppl,2009,3(8):883-911.
  • 5李荣,刘晓力.蛋白质组学在肿瘤研究中的应用与展望[J].肿瘤,2002,22(6):516-518. 被引量:1
  • 6YAMANOY,UZAWAK,SAITOK,e t a l.Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma[J].Int J Cancer,2010,126(2):437-449.
  • 7ASHRAFIAN H,O'FLAHERTY L,ADAM J,et al.Expression profiling in progressive stages of fumarate-hydratase deficiency:the contribution of metabolic changes to tumorigenesis[J].Cancer Res,2010,70(22):9153-9165.
  • 8LE MOGUEN K,LINCET H,DESLANDES E,et al.Comparative proteomic analysis of cisplatin sensitive IGROV1ovarian carcinoma cell line and its resistant counterpart IGROV1-R10[J].Proteomics,2006,6(19):5183-5192.
  • 9DENGHB,PAREKK,CHOWKC,et al.Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells[J].J Biol Chem,2002,277(17):15035-15043.
  • 10DIEDERICHS S,BULK E,STEFFEN B,et al.S100family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer[J].Cancer Res,2004,64(16):5564-5569.

二级参考文献18

共引文献2

同被引文献55

  • 1张慧珍,巴月,杨继要,范清堂,吴逸明.肺癌相关蛋白的筛选与鉴定[J].第四军医大学学报,2007,28(1):6-8. 被引量:9
  • 2Chang JW, Jeon HB, Lee JH, et al. Augmented expression ofperoxiredoxin I in lung cancer. Biochem Biophys Res Commun, 2001,289(2):507-512.
  • 3Ying W, Zhang K, Qian X,et al. Proteome analysis on an earlytransformed human bronchial epithelial cell line, BEP2D, afteralpha-particle irradiation. Proteomics, 2003, 3(1):64-72.
  • 4Wang Cl, Chien KY, Wang CL, et al. Quantitative proteomics revealsregulation of karyopherin subunit alpha-2 (KPNA2) and its potentialnovel cargo proteins in nonsmall cell lung cancer. Mol CellProteomics, 2012, 11(11):1105-1122.
  • 5Planque C, Kulasingam V,Smith CR, et al. Identification of fivecandidate lung cancer biomarkers by proteomics analysis ofconditioned media of four lung cancer cell lines. Mol Cell Proteomics,2009,8(12):2746-2758.
  • 6Zeng GQ, Zhang PF, Deng X,et al. Identification of candidatebiomarkers for early detection of human lung squamous cell cancer byquantitative proteomics. Mol Cell Proteomics, 2012, 11(6):M111.013946.
  • 7Alfonso P, Catala M, Rico-Morales ML, et al. Proteomic analysis oflung biopsies: Differential protein expression profile betweenperi tumoral and tumoral tissue. Proteomics, 2004, 4(2):442-447.
  • 8Chen G, Gharib TG, Thomas DG, et al. Proteomic analysis of eIF-5Ain lung adenocarcinomas. Proteomics, 2003, 3(4):496-504.
  • 9Kikuchi T, Hassanein M, Amann JM, et al. In-depth proteomicanalysis of nonsmall cell lung cancer to discover molecular targets andcandidate biomarkers. Mol Cell Proteomics, 2012, 11(10):916-932.
  • 10Tan F, Jiang Y, Sun N, et al. Identification of isocitrate dehydrogenase1 as a potential diagnostic and prognostic biomarker for non-small celllung cancer by proteomic analysis. Mol Cell Proteomics, 2012, 11(2):M111.008821.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部